| 22.67 Delayed Data As of 4:03pm ET |  -0.86 / -3.65%Today’s Change | 11.49 Today|||52-Week Range 25.96 | +19.63% Year-to-Date |
| BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up Nov 12 / Zacks.com - Paid Partner Content | Lilly (LLY) Tops Q3 Earnings, Lifts 2018 Outlook, Stock Up Nov 06 / Zacks.com - Paid Partner Content |
| Momenta (MNTA) Reports Narrower-Than-Expected Loss in Q3 Nov 09 / Zacks.com - Paid Partner Content | Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise Nov 02 / Zacks.com - Paid Partner Content |
| Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes Nov 07 / Zacks.com - Paid Partner Content | Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards? Nov 01 / Zacks.com - Paid Partner Content |
| Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year... Nov 07 / Zacks.com - Paid Partner Content | Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up Nov 01 / Zacks.com - Paid Partner Content |
| Previous close | 23.53 |
| Today’s open | 23.60 |
| Day’s range | 22.46 - 23.75 |
| Volume | 11,834,978 |
| Average volume (3 months) | 11,393,588 |
| Market cap | $24.0B |
| Earnings growth (last year) | -23,426.50% |
| Earnings growth (this year) | -27.03% |
| Earnings growth (next 5 years) | -1.65% |
| Revenue growth (last year) | +2.60% |
| P/E ratio | NM |
| Price/Sales | 0.85 |
| Price/Book | 1.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeiGene Ltd | +9.54 | +8.32% |
| AKRXAkorn Inc | -0.06 | -0.88% |
| OASMOasmia Pharmaceutica... | +0.33 | +6.92% |
| Next reporting date | February 7, 2019 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $22.5B |
| Annual profit (last year) | -$16.4B |
| Net profit margin | -72.66% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Kåre Schultz |
Executive Vice President- Global Operations Carlo de Notaristefani |
Corporate headquarters Petach Tikva, Hamerkaz |
